NDC 60505-0093-00 - Doxazosin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
60505-0093
Requested NDC
60505-0093-00
Package NDCs from labels
60505-0093-0, 60505-0093-1, 60505-0093-00
Manufacturer
A-S Medication Solutions
Effective date
2026-10-06
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Doxazosin - A-S Medication SolutionsA-S Medication Solutions2026-10-06HUMAN PRESCRIPTION DRUG LABEL
Doxazosin - Apotex Corp. | Apotex Inc.Apotex Corp. | Apotex Inc.2026-09-10HUMAN PRESCRIPTION DRUG LABEL
Doxazosin - Major PharmaceuticalsMajor Pharmaceuticals2026-08-05HUMAN PRESCRIPTION DRUG LABEL
Doxazosin - AvPAKAvPAK2026-03-24HUMAN PRESCRIPTION DRUG LABEL
Doxazosin - Northwind Health Company, LLCNorthwind Health Company, LLC2026-01-01HUMAN PRESCRIPTION DRUG LABEL
Doxazosin - American Health PackagingAmerican Health Packaging2025-09-17HUMAN PRESCRIPTION DRUG LABEL
Doxazosin - Denton Pharma, Inc. DBA Northwind PharmaceuticalsDenton Pharma, Inc. DBA Northwind Pharmaceuticals2023-01-05HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60505-0093-0Doxazosin100 in 1 BOTTLETABLET10015
60505-0093-1Doxazosin1000 in 1 BOTTLETABLET100015

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60505-0093DOXAZOSIN TABLET [APOTEX CORP.]14Current NDC, Legacy NDC, 2 package rows20240822_4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60505-0093-0EA - Each60505-00931f5fc4e6-c9a0-4bc8-b76d-c2e053ec2ecc12012-07-24
60505-0093-1EA - Each60505-0093061c86f0-6046-4d10-99d0-9b58c41dab4c12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DOXAZOSIN MESYLATEACTIVE INGREDIENT86P6PQK0MUDOXAZOSIN TABLET [APOTEX CORP.]4
DOXAZOSINACTIVE MOIETYNW1291F1W8DOXAZOSIN TABLET [APOTEX CORP.]4
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UDOXAZOSIN TABLET [APOTEX CORP.]4
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48DOXAZOSIN TABLET [APOTEX CORP.]4
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XDOXAZOSIN TABLET [APOTEX CORP.]4
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30DOXAZOSIN TABLET [APOTEX CORP.]4
DOXAZOSIN MESYLATEACTIVE INGREDIENT86P6PQK0MUDOXAZOSIN TABLET [MAJOR PHARMACEUTICALS]1
DOXAZOSIN MESYLATEACTIVE INGREDIENT86P6PQK0MUDOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING]1
DOXAZOSINACTIVE MOIETYNW1291F1W8DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS]1
DOXAZOSINACTIVE MOIETYNW1291F1W8DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UDOXAZOSIN TABLET [MAJOR PHARMACEUTICALS]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UDOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XDOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XDOXAZOSIN TABLET [MAJOR PHARMACEUTICALS]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 4 · 72 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DoxazosinDOXAZOSINREMEDYREPACK INC.bf2f7b41-f14d-4fcd-8db3-f507ca6ff78b2026-10-16Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.30a6bb83-f91b-4c4f-a849-4f2be3735a0e2026-10-14Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINA-S Medication Solutionsdcaf1417-8849-47f3-b400-e41dd8e9ba182026-10-08Warnings, Adverse reactionsExact identifier
rxcui: 197625
unii: 86P6PQK0MU
DoxazosinDOXAZOSINA-S Medication Solutionsbfea0b5b-9354-490f-88ff-008134077d242026-10-06Warnings, Adverse reactionsExact identifier
application number: ANDA075580
ndc (package): 50090-0734-1
ndc (package): 50090-0706-0
ndc (package): 50090-0734-0
ndc (package): 50090-0704-1
ndc (package): 50090-0704-0
ndc (package): 50090-0706-2
ndc (package): 50090-0701-0
ndc (package): 50090-0706-1
ndc (product): 50090-0706
ndc (product): 50090-0704
ndc (product): 50090-0734
ndc (product): 50090-0701
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
spl id: e4e04ecc-a6d1-41dd-bbdc-b4f462b4ca9b
spl set id: bfea0b5b-9354-490f-88ff-008134077d24
unii: 86P6PQK0MU
DoxazosinDOXAZOSINA-S Medication Solutions1e2f83a4-e800-4533-9d9a-15ea10d1cf922026-09-16Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINApotex Corp.4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b2026-09-10Warnings, Adverse reactionsExact identifier
application number: ANDA075580
ndc (package): 60505-0096-0
ndc (package): 60505-0094-1
ndc (package): 60505-0096-1
ndc (package): 60505-0095-1
ndc (package): 60505-0096-8
ndc (package): 60505-0093-1
ndc (package): 60505-0093-0
ndc (package): 60505-0095-0
ndc (package): 60505-0094-0
ndc (product): 60505-0095
ndc (product): 60505-0094
ndc (product): 60505-0096
ndc (product): 60505-0093
ndc11 (package): 60505009300
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
spl id: 81f80a89-6a61-35db-36ad-3cb9d7ecfbdc
spl set id: 4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b
unii: 86P6PQK0MU
DoxazosinDOXAZOSINMajor Pharmaceuticals3354196f-bbcf-4bc5-94f6-e6e8e132acb12026-08-05Warnings, Adverse reactionsExact identifier
application number: ANDA075580
ndc (package): 0904-5524-61
ndc (package): 0904-5522-61
ndc (package): 0904-5523-61
ndc (product): 0904-5524
ndc (product): 0904-5523
ndc (product): 0904-5522
rxcui: 197625
rxcui: 197626
rxcui: 197627
spl id: cf518081-e98c-4128-bfdc-e21cfee5d3dd
spl set id: 3354196f-bbcf-4bc5-94f6-e6e8e132acb1
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.71815e8f-33ed-4f36-a8ec-d4443151a9d82026-07-08Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINGolden State Medical Supply, Inc.54eeef3d-c906-37e7-e063-6294a90afca22026-06-23Warnings, Adverse reactionsExact identifier
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.ec06f008-37a1-4757-a3ee-0b4720912bc42026-06-11Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPD-Rx Pharmaceuticals, Inc.2ea9bb6b-a4f0-496a-b27b-4454167a4b702026-05-13Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINCardinal Health 107, LLC08521333-ff21-45ad-b99e-1f43d945d24d2026-04-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepack277c3278-4fe2-47ac-9115-15b417325ffd2026-04-13Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPreferred Pharmaceuticals Inc.2110eec5-949d-4718-ad6d-3629e5db8a072026-04-08Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPreferred Pharmaceuticals Inc.e046e0b7-f510-4318-9884-034d683864d42026-04-08Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAvPAKde9ab9a4-d8b8-8b36-e053-2a95a90aaa352026-03-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
ndc (package): 50268-222-11
ndc (package): 50268-225-11
ndc (package): 50268-225-15
ndc (package): 50268-223-11
ndc (package): 50268-224-15
ndc (package): 50268-222-15
ndc (package): 50268-223-15
ndc (package): 50268-224-11
ndc (product): 50268-223
ndc (product): 50268-224
ndc (product): 50268-222
ndc (product): 50268-225
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
spl id: 4dc6c398-ea92-808b-e063-6294a90ad2fc
spl set id: de9ab9a4-d8b8-8b36-e053-2a95a90aaa35
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAvKAREe3d381c1-3b2f-af70-f4e6-08d6202eed252026-03-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197628
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepacke2f5d7d2-21aa-4921-8035-da945d3c565c2026-03-04Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNuCare Pharmaceuticals, Inc.54116886-ea5e-5320-e054-00144ff8d46c2026-02-16Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepack8641cdb1-dc16-4a13-8a84-bc8f6d58b4d42026-02-13Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.